Bio-Path Holdings, Inc.
BPTH
$0.14
-$0.005-3.45%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.70M | 4.65M | 4.31M | 4.34M | 4.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.99M | 12.40M | 13.04M | 14.25M | 15.84M |
| Operating Income | -11.99M | -12.40M | -13.04M | -14.25M | -15.84M |
| Income Before Tax | -9.89M | -10.51M | -11.60M | -13.96M | -16.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.89 | -10.51 | -11.60 | -13.96 | -16.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.89M | -10.51M | -11.60M | -13.96M | -16.08M |
| EBIT | -11.99M | -12.40M | -13.04M | -14.25M | -15.84M |
| EBITDA | -11.94M | -12.35M | -12.98M | -14.16M | -15.76M |
| EPS Basic | -7.38 | -12.24 | -17.90 | -27.38 | -35.75 |
| Normalized Basic EPS | -4.61 | -7.65 | -11.19 | -17.11 | -22.34 |
| EPS Diluted | -7.38 | -12.24 | -17.90 | -27.38 | -35.75 |
| Normalized Diluted EPS | -4.61 | -7.65 | -11.19 | -17.11 | -22.34 |
| Average Basic Shares Outstanding | 9.59M | 5.89M | 3.38M | 2.16M | 1.91M |
| Average Diluted Shares Outstanding | 9.59M | 5.89M | 3.38M | 2.16M | 1.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |